Prevalence of fish-detected gains at 3q26 in squamous cell lesions of the lung

被引：0
|
作者：
Pelosi, G
Del Curto, B
Nicholson, A
Veronesi, G
Spaggiari, L
Viale, G
机构：
[1] European Inst Oncol, Div Pathol & Lab Med, Milan, Italy
[2] Univ Milan, Sch Med, Milan, Italy
[3] Royal Brompton Hosp, Dept Histopathol, London SW3 6LY, England
[4] European Inst Oncol, Div Thorac Surg, Milan, Italy
来源：
LUNG CANCER | 2004年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [21] Evaluation of hTERC (3q26) gain by fluorescence in situ hybridization (FISH) to predict the behavior of oral epithelial precursor lesions
    Gabba, S.
    Giannini, E.
    Borghi, L.
    Fellegara, G.
    Marcialis, C.
    Grugni, M.
    Foschini, M. P.
    Repetti, E.
    Dorji, T.
    Grazioli, V.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S772 - S773
  • [22] DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma
    Bjorkqvist, AM
    Husgafvel-Pursiainen, K
    Anttila, S
    Karjalainen, A
    Tammilehto, L
    Mattson, K
    Vainio, H
    Knuutila, S
    GENES CHROMOSOMES & CANCER, 1998, 22 (01): : 79 - 82
  • [23] Novel combination therapies against AML with 3q26 lesions and EVI1 overexpression
    Birdwell, Christine
    Fiskus, Warren C.
    Mill, Christopher P.
    Davis, John A.
    Jin, Qi
    DiNardo, Courtney D.
    Takahashi, Koichi
    Horrigan, Stephen
    Kadia, Tapan M.
    Daver, Naval
    Bhalla, Kapil N.
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Overexpression of chromosome 3q26-29 miRNAs in squamous cell carcinoma of the lung
    Qian, Jun
    Ji, Xiangming
    Zou, Yong
    Hoeksema, Megan
    Chen, Heidi
    Massion, Pierre P.
    CANCER RESEARCH, 2014, 74 (19)
  • [25] Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma
    Liu, Yi
    Yin, Ning
    Wang, Xue
    Khoor, Andras
    Sambandam, Vaishnavi
    Ghosh, Anwesha B.
    Fields, Zoe A.
    Murray, Nicole R.
    Justilien, Verline
    Fields, Alan P.
    CELL REPORTS, 2020, 30 (03): : 771 - +
  • [26] Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung
    Sugita, M
    Tanaka, N
    Davidson, S
    Sekiya, S
    Varella-Garcia, M
    West, J
    Drabkin, HA
    Gemmill, RM
    CANCER GENETICS AND CYTOGENETICS, 2000, 117 (01) : 9 - 18
  • [27] Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
    Christine E. Birdwell
    Warren Fiskus
    Tapan M. Kadia
    Christopher P. Mill
    Koji Sasaki
    Naval Daver
    Courtney D. DiNardo
    Naveen Pemmaraju
    Gautam Borthakur
    John A. Davis
    Kaberi Das
    Sunil Sharma
    Stephen Horrigan
    Xinjia Ruan
    Xiaoping Su
    Joseph D. Khoury
    Hagop Kantarjian
    Kapil N. Bhalla
    Leukemia, 2024, 38 : 545 - 556
  • [28] Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer
    Liu, Jinfeng
    Liu, Sijie
    Li, Dan
    Li, Hongbin
    Zhang, Fan
    GLOBAL MEDICAL GENETICS, 2024, 11 (02): : 150 - 158
  • [29] Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
    Birdwell, Christine E.
    Fiskus, Warren C.
    Kadia, Tapan M.
    Mill, Christopher P.
    Davis, John A.
    Das, Kaberi
    Horrigan, Stephen
    Bhalla, Kapil N.
    CANCER RESEARCH, 2023, 83 (07)
  • [30] Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
    Birdwell, Christine E.
    Fiskus, Warren
    Kadia, Tapan M.
    Mill, Christopher P.
    Sasaki, Koji
    Daver, Naval
    Dinardo, Courtney D.
    Pemmaraju, Naveen
    Borthakur, Gautam
    Davis, John A.
    Das, Kaberi
    Sharma, Sunil
    Horrigan, Stephen
    Ruan, Xinjia
    Su, Xiaoping
    Khoury, Joseph D.
    Kantarjian, Hagop
    Bhalla, Kapil N.
    LEUKEMIA, 2024, 38 (03) : 545 - 556
12345